Carmat Heart Implant Could Help Thousands of Patients

Carmat Heart Implant Could Help Thousands of Patients

Paris: Biomedical firm Carmat announced first artificial heart transplant on Friday. The patient aged in 70s (name withheld) at Georges Pompidou Hospital in Paris was conscious and speaking to relatives, as per official statement. Carmat CEO Marcello Conviti was delighted about the first implant. He added that it will be premature to draw conclusions and the medical team is keeping close watch on the patient in intensive care unit.

Carmat artificial heart would beat for five years and weighs nearly 3 times the real heart at 900 grams. The company aims to help thousands of patients who die waiting for a donor for heart transplant. The company will implant the device in three patients in coming weeks. In next phase, the company will carry on implants in 20 more patients next year.

While congratulating the medical team, French health minister said, “This news brings great pride to France. It shows the advancement of France in healthcare and medical innovation.”

The Carmat artificial heart would cost around Euro 135,000 – 150,000. As per company estimates, nearly 100,000 patients in Europe and United States are in need of heart transplant.

During the first phase of trials, the company will access the medical condition of patients after one month of implant. Carmat has been authorized for carrying out transplants in France, Poland, Belgium, Saudi Arabia and Slovenia.

As per reports published in Le Monde on Saturday, the company could look for investors to expand its operations after success of phase I trials. Truffle Capital funded launch of Carmat. In second series of funding, Carmat raised funds from stock market in year 2011.


FrenchTribune Specials

While you may share your love for coffee with large number of people across the world, there is a possibility that consumption level may differ greatly. Why some people could only consume less amount of coffee, while others can take several cups a day is now defined by presence of a gene variant in an individual’s body.

The study that...

Exxon reports 46% decline in First Quarter earning

On Thursday, Exxon reported a 46% decline in earnings in the first quarter, by earning $4.9 billion compared with $9.1 billion in the same quarter a year ago. Exxon's top and bottom lines declined due to lower oil prices.

It was the...

Most Popular

MIT team publishes slow-motion video of sneeze

Lydia Bourouiba, mathematical physicist and head of a...

Report: Google, Facebook, and Twitter are ‘the lifeblood of Daesh’

According to a new report released by the UK Home...

Milk protein helps make edible packaging for food products

Most of the food products come wrapped in plastic...

Poll

Can Greece Come out of Economic Problems: